WHO ICTRP trial
A multicenter phase II, single arm study of Durvalumab (MEDI 4736) with…
EUCTR2020-005942-41-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2020-005942-41-IT |
|---|---|
| Public title | A multicenter phase II, single arm study of Durvalumab (MEDI 4736) with Carboplatin plus Etoposide for 4 cycles followed by Durvalumab maintenance in patients with metastatic pulmonary large-cell neuroendocrine carcinoma (LCNEC) - DUPLE trial |
| Scientific title | A multicenter phase II, single arm study of Durvalumab (MEDI 4736) with Carboplatin plus Etoposide for 4 cycles followed by Durvalumab maintenance in patients with metastatic pulmonary large-cell neuroendocrine carcinoma (LCNEC) - DUPLE trial - DUPLE Trial |
| Primary sponsor | GRUPPO ONCOLOGICO ITALIANO DI RICERCA CLINICA (GOIRC) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Italy |
| Conditions | treatment-naïve patients with metastatic pulmonary large-cell neuroendocrine carcinoma (LCNEC) MedDRA version: 20.0 Level: PT Classification code 10071542 Term: Neuroendocrine carcinoma metastatic System Organ Class: 10029104 - Neoplasms… |
| Interventions | Trade Name: CARBOPLATINO AHCL - 50 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FLACONCINO DI VETRO DA 5 ML Product Name: Carboplatino Product Code: [Carboplatino] Pharmaceutical Form: Concentrate for solution for infusion INN or… |
| Registration date | Nov 19, 2021 |
| Target size | 49 |
| Secondary IDs | GOIRC-05-2020 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: